Apollo Medical Holdings Inc
NASDAQ:ASTH
Wall Street
Price Targets
ASTH Price Targets Summary
Apollo Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ASTH
is 37.17 USD
with a low forecast of 26.26 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ASTH's stock price target?
Price Target
37.17
USD
According to Wall Street analysts, the average 1-year price target for
ASTH
is 37.17 USD
with a low forecast of 26.26 USD and a high forecast of 52.5 USD.
What is Apollo Medical Holdings Inc's Revenue forecast?
Projected CAGR
21%
For the last 3 years the
compound annual growth rate for
Apollo Medical Holdings Inc's revenue is
38%.
The projected
CAGR
for the next 4 years is
21%.
What is Apollo Medical Holdings Inc's Operating Income forecast?
Projected CAGR
13%
For the last 3 years the
compound annual growth rate for
Apollo Medical Holdings Inc's operating income is
-3%.
The projected
CAGR
for the next 4 years is
13%.
What is Apollo Medical Holdings Inc's Net Income forecast?
Projected CAGR
30%
For the last 3 years the
compound annual growth rate for
Apollo Medical Holdings Inc's net income is
-14%.
The projected
CAGR
for the next 3 years is
30%.
